Calcium Metabolism Disorders: Clinical Trials

535 trials for Calcium Metabolism Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

285 completed, 91 unknown, 59 recruiting, 27 not yet recruiting. 116 Not applicable, 86 Phase 2, 57 Phase 3, 57 Phase 4, 31 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable116Completed 60, Unknown 20, Recruiting 13, Not yet recruiting 9, Active not recruiting 7, Withdrawn 5, Terminated 2
Phase 286Completed 57, Terminated 6, Not yet recruiting 5, Active not recruiting 4, Recruiting 4, Unknown 4, Withdrawn 4, Enrolling by invitation 2
Phase 357Completed 38, Unknown 5, Not yet recruiting 3, Recruiting 3, Terminated 3, Withdrawn 3, Active not recruiting 2
Phase 457Completed 32, Unknown 13, Recruiting 4, Terminated 4, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1
Phase 131Completed 21, Unknown 4, Terminated 3, Not yet recruiting 2, Recruiting 1
Early Phase 18Completed 5, Recruiting 2, Withdrawn 1

Follow Calcium Metabolism Disorders: new trials by email Literature Review of Calcium Metabolism Disorders trials Research Report on Calcium Metabolism Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-Interleukin-6 (IL6) in Calciphylaxis
Tocilizumab - Calciphylaxis
Phase 1Not yet recruitingBoston Medical Center102027-09-012026-07-16
Analysis of the Influence of Dialysis Fluid Composition on Vascular Calcification in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Citrate dialysate with magensium supplementation, Acetate dialysate - Vascular Calcification, Hemodialysis
Not applicableNot yet recruitingHospital Clinic of Barcelona802027-01-022026-09-16
Emerging Indications for Hyperbaric Oxygen Treatment
Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis
Phase 4Not yet recruitingJay C. Buckey Jr.1002026-11-012026-09-09
Ramipril vs. Amlodipine in Pediatric Hemodialysis Patients
Ramipril tablet, Amlodipine tablet - Endothelial Dysfunction, End-Stage Renal Disease
Phase 3Not yet recruitingAin Shams University502026-11-012026-10-21
Diagnostic Work-up of Nephrocalcinosis in Children
Nephrocalcinosis
Not yet recruitingAssiut University402026-10-202026-10-20
Tissue Validation of Mammographic Breast Arterial Calcification in Mastectomy Specimens
Breast Cancer, Vascular Calcification
Not yet recruitingSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital1002026-10-152026-10-15
Ionized Calcium as a Severity Marker in Septic Shock Patients
Sepsis, Septic Shock
Not yet recruitingAssiut University1602026-10-012026-09-10
Osteoporosis & Renal Disease: Research in Primary Health Care Services
Fracture risk assessment tool (FRAX), Dual-Energy X-ray Absorptiometry (DXA) - Osteoporosis, Chronic Kidney Disease Mineral and Bone Disorder
Not yet recruitingUniversidade do Porto6222026-10-012026-09-30
Study of EPN-701 for the Treatment of Calciphylaxis
EPN-701 (Oral), Placebo (Normal Saline) - Calciphylaxis
Phase 2Not yet recruitingSagar U. Nigwekar, MD, MMSc602026-10-012026-09-14
Molecular Imaging to Identify Predictors of Aortic Valve Disease Activity
AORTIC VALVE DISEASES, Calcification; Heart
Not yet recruitingMassachusetts General Hospital1002026-09-302026-09-16
The GranStone Trial
empagliflozin (Jardiance) 25 mg, Losartan 100 mg - Paraffinoma, Granuloma, Foreign-Body
Phase 2 / Phase 3Not yet recruitingMartin Blomberg Jensen1002026-09-012026-09-18
Post-Marketing Clinical Study of High-Pressure Cutting Balloon
High pressure cutting balloon, Non-cutting balloon - Coronary Artery Disease, Calcification
Not applicableRecruitingBrosMed Medical Co., Ltd2802026-09-012026-09-22
Morphology in Oral Rare Syndromes & Artificial Intelligence for Clinical Diagnosis
intra-oral 3D optical impression - Osteogenesis Imperfecta, Rare Bone Disorders
Not applicableNot yet recruitingUniversity Hospital, Bordeaux2402026-09-012026-06-24
Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a)
Setmelanotide - Pseudohypoparathyroidism Type 1a, Obesity
Phase 2Enrolling by invitationMassachusetts General Hospital12026-07-212026-07-23
Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X-Linked Hypophosphatemia
No treatment given - X-linked Hypophosphatemia (XLH)
WithdrawnNovo Nordisk A/S2026-07-072026-08-28
Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD
Low-dose Colchicine at 0.5mg daily, Usual Care - Chronic Kidney Disease Mineral and Bone Disorder, Hypertension
Phase 2Not yet recruitingUniversity of Texas Southwestern Medical Center602026-07-012026-06-22
Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Femoral Stenting (SKYWARD Trans-Femoral IDE [Investigational Device Exemption] Study)
Carotid Intravascular Lithotripsy - Carotid Artery Calcification, Carotid Artery Diseases
Not applicableNot yet recruitingShockwave Medical, Inc.1852026-07-012026-07-31
Medium Cut-Off and High-Flux Membranes on Mineral and Bone Metabolism in Hemodialysis Patients
Medium Cut-Off Hemodialysis Membrane, High-Flux Hemodialysis Membrane - End Stage Kidney Disease (ESKD), Hemodialysis
Not applicableActive not recruitingGazi University302026-07-012026-09-14
Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)
Carotid Intravascular Lithotripsy (IVL) - Carotid Artery Calcification, Carotid Artery Diseases
Not applicableRecruitingShockwave Medical, Inc.1852026-06-222026-10-15
NIRAF-Guided Parathyroid Identification During Thyroidectomy
Wearable Near-Infrared Autofluorescence Imaging System - Hypocalcemia, Hypoparathyroidism
Not applicableNot yet recruitingSs. Cyril and Methodius University of Skopje2802026-06-012026-06-01

Showing 20 of 535. Sign in to see all of them.

Narrower conditions

Hypocalcemia (94)  ·  Calcinosis (89)  ·  Vascular Calcification (81)  ·  Chronic Kidney Disease-Mineral and Bone Disorder (73)  ·  Renal Insufficiency, Chronic (62)  ·  Hypercalcemia (50)  ·  Familial Hypophosphatemic Rickets (49)  ·  Kidney Failure, Chronic (37)  ·  Rickets (36)  ·  Hyperparathyroidism, Secondary (34)  ·  Osteomalacia (34)  ·  Hypoparathyroidism (32)  ·  Vitamin D Deficiency (27)  ·  Bone Diseases (26)  ·  Hyperparathyroidism (23)

Broader conditions

Nutritional and Metabolic Diseases (534)  ·  Metabolic Diseases (528)  ·  Musculoskeletal Diseases (223)  ·  Urogenital Diseases (210)  ·  Female Urogenital Diseases and Pregnancy Complications (209)  ·  Male Urogenital Diseases (207)  ·  Female Urogenital Diseases (206)  ·  Urologic Diseases (204)  ·  Pathological Conditions, Signs and Symptoms (199)  ·  Nutrition Disorders (196)  ·  Kidney Diseases (195)  ·  Bone Diseases, Metabolic (194)  ·  Bone Diseases (190)  ·  Deficiency Diseases (190)

Interventions

burosumab (22)  ·  Cholecalciferol (20)  ·  Calcitriol (18)  ·  Vitamin D (14)  ·  Cinacalcet (13)  ·  sodium thiosulfate (12)  ·  asfotase alfa (10)  ·  Blood Specimen Collection (9)  ·  Calcium (9)  ·  Calcium Carbonate (8)  ·  Ergocalciferols (7)  ·  Sevelamer (7)  ·  etelcalcetide hydrochloride (7)  ·  paricalcitol (7)  ·  Saline Solution (6)

Sponsors

Alexion Pharmaceuticals, Inc. (13)  ·  Kyowa Kirin Co., Ltd. (12)  ·  Amgen (9)  ·  Hospices Civils de Lyon (9)  ·  Mayo Clinic (8)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (8)  ·  Assiut University (7)  ·  Massachusetts General Hospital (7)  ·  Kyowa Kirin, Inc. (6)  ·  National Institute of Dental and Craniofacial Research (NIDCR) (6)  ·  University of Aarhus (6)  ·  Vanderbilt University Medical Center (6)  ·  Yale University (6)  ·  Columbia University (5)  ·  Kyowa Kirin Pharmaceutical Development Ltd (5)

Countries

United States (176)  ·  France (53)  ·  Canada (37)  ·  China (36)  ·  United Kingdom (34)  ·  Italy (33)  ·  Germany (31)  ·  Denmark (28)  ·  Spain (23)  ·  Netherlands (18)  ·  Japan (16)  ·  Belgium (15)  ·  Australia (14)  ·  Turkey (Türkiye) (14)  ·  Poland (13)

Top investigators

Jaclyn Tamaroff, MD (3)  ·  Smita Jha, M.D. (3)  ·  Thomas Nickolas, MD, MS (3)  ·  Alex Gold, MD (2)  ·  Amy Zhang, PhD (2)  ·  Craig Sherman, MD (2)  ·  Ditte Hansen, MD, PhD (2)  ·  Ditte Hansen, Medical doctor, professor (2)  ·  Jing Chen, MD (2)  ·  M. Louise Markert, MD, PhD (2)

Results publications

PMID 39151033, PMID 40576086, PMID 26529632, PMID 32417537, PMID 32721016, PMID 32762706, PMID 34231877, PMID 39186385, PMID 40668552, PMID 40962182, PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 20236866, PMID 22169620, PMID 23102518, PMID 25919461, PMID 27699270, PMID 33305842, PMID 36854566, PMID 38189593, PMID 10089993, PMID 10584989, PMID 10816185, PMID 11443763, PMID 12110413, PMID 12200646, PMID 12605179, PMID 12935835, PMID 12937218, PMID 14581387, PMID 14582032, PMID 15284307, PMID 15810001, PMID 15894595, PMID 15930998, PMID 15942915, PMID 15961949, PMID 16227647, PMID 16675931, PMID 16973975, PMID 17130273, PMID 17164301, PMID 17190895, PMID 17284531, PMID 17468488, PMID 17652219, PMID 18007136, PMID 18046319

NIH funding

R01CA212147 (3), 2018 (2), K12HD043494 (2), R01AI047040 (2), R01AI054843 (2), 1IK2CX000549-01 (1), 1RC1HD063562 (1), 1UL1TR001863-01 (1), 2008 (1), 2014 (1), 2017 (1), 2019 (1), K23DK101689 (1), K23DK136930 (1), N01CM00039 (1)